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SUMMARY 
The authors report four cases of Monopolar Depressed patients who developed manic features for 
the first time while on tricyclic antidepressant therapy. The phenomenon is viewed as tricyclic antidepressant 
induced mania. The manic symptoms occurred Ute in therapy, with moderate doses of tricyclic antidepress-
ants (125-150 mg per day) and wcreeasily controlled with antipsychotic medication. Factors relating to age 
of patients, metabolic products of tricyclic antidepressants and central nor-adrenergic and dopaminergic 
systems are considered important and their role has been discussed. 
A clinical phenomenon infrequently 
reported as a complication of Tricyclic 
Antidepressant (TCA) therapy is the deve-
lopment of mania induced by the drug. 
In a known bipolar patient the develop-
ment of mania may be taken as a phase of 
illness. However, manic features deve-
loping for the first time in a unipolar de-
pressed patient in temporal correlation with 
TCA therapy raises some important thera-
peutic and etiological issues concerning 
affective illness. It has been suggested that 
TCA's have the potential to induce mania 
by producing crucial biochemical changes 
in the brain noradrenergic (Shildkraut, 
1965 ; Bunney, 1978) dopaminergic (Gra-
bowska et al., 1974 ; Halaris eta/., 1975 ; 
Bevan et al., 1975) and serotinergic 
(Carlsson et al., 1969 ; Meek and Werdinius, 
1970) pathways. 
Bunney et al. (1978) reviewed the litera-
ture on this phenomenon and noted 160 
episodes of mania or hypomania in patients 
on TCA's ; 60% of these patients showed 
past histories of manic behaviour, suggest-
ing possible sensitivity to the tricyclic 
medication. The authors further suggested 
that in addition to medication, other factors 
such as environmental stresses may also play 
a role in the onset of manic behaviour. 
Angst (1970) reported this transition to 
occur with a frequency of 3.75% 
with imipramine hydrochloride. Bunney 
(1978) reported 8.6% incidence of mania 
or hypomania in 2,346 treatment with 
TCA's. Capstick (1973) described hypo-
manic episodes in three of 46 patients who 
were treated with clomipramine. Two of 
these patients had previously experienced 
a hypomanic episode. Van Scheyen and 
Van Kammen (1979) observed mania in six 
of 25 clomipramine treated and one of 25 
amitriptyline hydrochloride - treated uni-
polar depressed patients. The present article 
is an addition to the continuing literature 
on the topic and reports four cases of manic 
behaviour induced in unipolar depressed 
patients who were receiving TCA 
therapy. 
METHOD 
The patient sample for the present 
report was derived from two recently com-
pleted projects on anti-depressant therapy 
at the Department of Psychiatry, King 
George's Medical College, Lucknow. 
Study No. 1 : entitled 'Dose Effects 
of Antidepressant Medication in Different 
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Populations' is a WHO sponsored multi-
centred study with Lucknow being one 
of the centres. The study commenced in 
December 1978 and was completed in May, 
1980. The sample comprised of patients 
diagnosed as depressed according to strin-
gent Exclusion & Inclusion Criteria and 
diagnosis of depression according to Code 
nos. 296.1 ; 296.3 ; 298.0, 300.4 and 309.1 
ofICD-9(WHO, 1977). On inclusion the 
patient received, according to a previously 
prepared randomization list, neutrally 
labelled medication containing either 75 
mg. or 150 mg. of imipramine per day. 
The dosage was fixed for four weeks. Fifty 
per cent of the full dosage was given during 
the first 3 days. From the fourth day on-
wards until the end of fourth week the full 
dosage was given. Subsequently the patient 
was free to receive imipramine in dosage 
adjusted according to clinical assessment 
and was followed up for the next two months. 
Assessments were done at the initiation of 
therapy, 14th day, 28th May, 42nd day 
and 84th day. Evalualional tools were 
Hamilton Rating Scale for Depression 
(HRSD) (Hamilton, 1960), WHO 
Schedule for Standardised Assessment of 
Depressive Disorders (SADD), Rating Scale 
for Side Effects (SES) (adopted from 
Asberg et al., 1970) and Clinical Global 
Impression Scale (CGIS). 
A total of 48 patients were included 
in the study out of which 34 were of manic-
depressive psychosis, depressed type (uni-
polar depression). Ages ranged from 20 
yrs. to 65 yrs., with a mean age of 45.3 
years. There were 15 males and 19 
females. 
Study No. 2 : was entitled "Relation-
ship between plasma amitriptyline level and 
therapeutic response in depressives". The 
study began in August 1979 and com-
pleted in April 1980 with a sample of 30 
patients of manic depressive psychosis, de-
pressed type (monopolar depression)
1. Only 
those patients with a score of 16 or above 
on HRSD were included in the study. On 
inclusion each patient received a single 
nightly dose of 75 mg. of amitriptyline, 
which was increased to 150 mg. after 3 days, 
which he continued to receive till the 
end of the active treatment period of six 
weeks. Evaluaton with the help of HRSD, 
SES and CGIS was done at the start of 
therapy and on the 14th, 28th and 42nd 
day. The sample consisted of 21 males and 
9 females and their ages ranged from 30 to 
56 years with the mean age of 39.8 years. 
Case Reports : 
Case-l : 
R. J. a 56 years old male was admitted 
with depressive symptoms of 15 days' 
duration. Over the past 3 years he had 
had 3 depressive episodes. The first episode 
occurred when he was 53 years old and 
lasted for 1$ years. The 2nd episode 
occurred 3 months after recovery from the 
first episode and was of 2 months duration. 
Six months later the 3rd episode occurred 
and lasted for another 2 months. Each 
time he was hospitalized and treated with 
antidepressants (Imipramine, Amitriptyline) 
and E.C.T. He remitted on each occasion 
but failed to continue the therapy after 
discharge from the hospital. 
Medical history was uneventful. In 
family there is history of schizophrenia 
in son. 
During the present depressive episode, 
he was part of the WHO study mentioned 
above. He received 75 mg/day of imipra-
mine for 3 days and 150 mg/day till the 
end of 28 days. Subsequently he received 
125 mg. of imipramine per day. He showed 
good improvement with this therapy. The 
'In actuality the diagnostic criteria adopted for this study was of Primary Depression (Feighner et al, 1972) 
Since all the patients of this study if diagnosed according to ICD-9 would fall in the category of Manic-
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formity labelled them as such in the text given above. 380  B. B. SETHI it al. 
Imipramine and Amitriptyline-lnduced Mania in Unipolar Depressed Patients (.A'=4 out q/"64) 
Patient 
(Sex) 
RJ. 
H.D.T. 
K..B. 
S.L. 
(M) 
(M) 
(M) 
(M) 
No. or past 
depressive 
episodes 
3 
1 
2 
21 
Age at onset 
of depression 
(year) 
53 
45 
35 
25 
Age at onset 
of Mania 
(year) 
56 
50 
39 
56 
No. of days 
receiving 
drugs prior 
to switch 
47 
37 
70 
84 
Dosage in 
mg/day* 
125, I 
150, A 
150, A 
150, A 
Family 
History 
Schizophrenia 
— 
Schizophrenia 
— 
•I => Imipramine; A=Amitriptyline 
score of HRSD was 26 at baseline, 16 on 
14th day, 5 on 28th day and 3 on 42nd 
day. Soon after, the patient was given 
leave to go home for 5 days to participate 
in the marriage of his nephew. While at 
home and on 47th day of trial the patient 
showed a marked change in his behaviour 
and was immediately brought back to the 
hospital. At home he was reported to have 
become overactive, talkative and grandiose. 
He was irritable and became combative when 
restricted. He also indulged in financial 
transactions much beyond his means. On 
examination he was distractible, euphoric, 
grandiose and manifested flight of ideas. 
He had psychomotor excitation and spent 
Sleepless nights singing songs. His anti-
depressant medication was discontinued and 
he was started on chlorpromazine 500 
mg/day with night time nitrazepam (10mg.). 
He recovered -in 10 days time when all 
the features of mania disappeared. At 
follow-up, on 84th day, the patient was 
found to be euthymic. 
Case-2 : 
H.D.T., 50 years old male was hos-
pitalized in a depressive state which began 
to appear 1$ months ago. In past he had 
only one depressive episode which occurred 
at the age of 45 years. He was treated by a 
general practitioner but the exact mode of 
therapy employed is not known. There is 
no family history of any psychiatric dis-
order. 
During the present episode he parti-
cipated in the amitriptyline study, the treat-
ment regimen of which has been described 
above (study No. 2). He showed good 
improvement and scores on HRSD were 
32 at baseline, 17 on 14th day and 12 on 
28th day. On 37th day of therapy a change 
in his behaviour was noticed in form of 
irritability, talkativeness and tendency to 
order the hospital personnel and other 
patients. On examination he was elated, 
grandiose and manifested flight of ideas. 
Amitriptyline was discontinued and chlor-
promazine was started (300 mg/day). He 
showed rapid improvement and attained 
euthymia within twelve days of onset of 
manic features. 
Case-3 : 
Mr. K. B., a 39 years old male pre-
sented to us with depressive symptoms of 3 
weeks duration. Similar episodes in the 
past had lasted for two and a half months 
without resorting to any medication. He 
has had two episodes prior to the present 
one ; the first occurring at the age of 35 
years. There is family history of schizo-
phrenia in a first cousin. He participated 
in the amitriptyline study. His HRSD 
scores were : 29 at base line, 20 on 14th 
day, 15 on 28th day and 11 on 42nd day 
soon after which he was discharged with 
the advice to continue amitriptyline (150 
mg/day) and to attend O.P.D. for follow-
up. A month later the patient was brought TRICYCLIC ANTI-DEPRESSANT INDUCED MANIA  361 
to the hospital in an excited state by his 
son who informed that the patient was 
talking excessively and was making plans 
for his business on a grand scale. The 
patient had continued antidepressant medi-
cation till the time of onset of these features, 
when it was discontinued. On examination 
the patient was hyperactive, intrusive, irri-
table and demanding. These manic features 
are reported to have developed within 
one day. Patient was advised phenothia-
zines and to turn up the next day for admis-
sion but he did not do so. No information 
was available about him till the time of 
reporting of these cases. 
Case-A : 
S. L., a 56 years old male was ad-
mitted with a depressive illness of 2 months 
duration. He had his first depressive episode 
at the age of 25 years. Subsequently de-
pressive episodes reccurred nearly every 
year, each never lasting for more than 
two to three months. For initial twelve years 
he took indigenous preparations, but later 
he consulted a psychiatric facility where 
he was hospitalized four times. Each time 
he was treated with TCA (Imipramine) 
therapy and showed complete remission of 
symptoms, but never continued with main-
tenance treatment. There was no family 
history of any psychiatric illness. 
After admission to our hospital for the 
present episode he participated in study 
No. 2. HRSD ratings were 30 at baseline, 
23 on 14th day, 17 on 28th day and 13 on 
42nd day. Amitriptyline in the same dose 
was continued as maintenance therapy 
after completion of the trial period of 6 
weeks. On 84th day he was informed 
that he was to be discharged about which 
the patient was quite reluctant. The next 
morning he got up early and started singing 
religious songs. On examination he pre-
sented with an elated affect and an element 
of grandiosity in thoughts. He spent money 
indiscriminately. The antidepressant medi-
cation was discontinued and after 3 days 
he was prescribed Chlorpromazine 300 
mg/day in divided doses. He was euthymic 
within 10 days. 
COMMENTS 
In the four cases described above 
there was no history of mania prior to the 
current one. Case-1 had history of three 
depressive episodes, Case-3 had two previous 
depressive episodes and Case-4 had a history 
of twenty one circumscribed depressive 
episodes. Only Case-2 had history of a 
single episode of depression in the past (See 
Table). Three out of four patients were 
above fifty years of age whereas the fourth 
one was thirty-nine years old. All the 
cases had passed the usual age for onset 
of mania i.e. twenty four years (Bunney 
el al., 1978) thereby considerably decreasing 
the probability of these cases being bipolar 
who had not yet manifested their first 
manic episode. The older age of onset of 
mania and the temporal correlation with 
TCA therapy as observed by us supports 
a similar observation by Van Scheyen and 
Van Kammen (1979) and is a point in 
favour of TCA's having been responsible 
for mania. 
Another fact observed in our series was 
that the manic features appeared quite late 
in the course of anti-depressant therapy. 
For instance, all four of our patients had 
received TCA therapy for more than four 
weeks (from 37-84 days) before manifesting 
manic features and took from 1 to 3 days 
to develop a full fledged picture of mania. 
They were all on moderate doses of TCA's 
(125 mg—150 mg per day). Wagensommer 
(1964) reports that the onset of TCA-
induced mania can occur either suddenly 
as a switch into mania during short-term 
treatment of depression or slowly during 
maintenance (lower dose) treatment. There-
fore our patients appear to belong to the 
latter category. 
A crucial role of TCA metabolism and 
age of patients is introduced by the observ-
ations of Van Scheyen and Van Kammen 382  B. B. SETHI it al. 
(1979) who noted in their report on Clo-
mipramine-induced mania in Unipolar De-
pression that older the patients, the longer 
they were receiving clomipramine or ami-
triptyline before they switched into mania. 
They posit that by this equation one could 
expect younger rather than older patients 
to be more vulnerable to the switch. How-
ever, they add that in case of elderly sub-
jects because drug metabolism decreases 
with age, one may assume a role for the 
desmethyl clomipramine metabolite which 
is more potent than the mother compound 
in blocking dopamine, norepinephrine, and 
serotonin uptake (Hyttel, 1977). Further, 
patients in whom demethylation occurs at 
a fast rate may, then, also be more vulnerable 
to the switch than older patients in whom 
the rate of demethylation is slow. The 
authors support their observations on the 
potential role of demethylated metabolites 
of TCA in the induction of mania by quot-
ing the work of U'Prichard et al. (1978), 
who related the more potent psychomotor 
activating effects of these demethylated 
metabolites to the larger a-noradrenergic 
receptor blocking properties compared to 
those of the mother compound. Since our 
patients were in the older age group it may 
be that our patients belong to a group of 
patients who are prone to develop mania, 
sensitive to the demethylated products of 
TCA's and are fast metabolizers. 
The duration of mania could not be 
studied fully in an intervention free state 
due to ethical and practical reasons. All 
in all, in three cases for which details of 
manic episodes are available, the duration 
did not exceed two weeks, which is less than 
the period of 15 to 49 days reported by 
Van Scheyen and Van Kammen (1979). 
The switch on to mania of unipolar 
depressed patients rahes the possibility that 
basically these patients are potential bipolars 
(especially if there is evidence of bipolar 
affective illness in relatives) who manifest 
both the phases of illness under appropriate 
bio-chemical and environmental conditions. 
However, none of our patients had family 
history of affective illness although there 
was evidence of schizophrenic illness in 
two of our patients. Therefore we cannot 
assume that our patients were genetically 
or biochemically linked or predisposed to 
bipolar illness. 
We are in the process of following up 
our cases to observe the future course of 
illness and any further instance of drug 
related behavioural changes. However, Van 
Scheyen and Van Kammen (1979) in their 
study followed their cases for six to seven 
years and did not find a single instance 
of switch into mania without TCA treat-
ment. This again points towards TCA's 
and their property to bring about crucial 
biochemical changes and the condition of 
drug induced mania. 
The biochemical theory of depression 
posits a functional decrease in central nore-
pinephrine (NE) (Shildkraut, 1965 ; Bunney 
and Davis, 1965), whereas an increased 
functional level of NE and dopamine (DA)-
is the biochemical accompaniment of a bi 
polar patient switching into mania (Bunney, 
1978, Bunney et al., 1972 ; Murphy et al. 
1977 ; Bunney et al., 1977 ; Gerner et al., 
1976). Tricyclic antidepressants affect NE 
(Shildkraut, 1965 ; Bunney & Davis, 
1965), serotonin (Carlsson et al., 1969 ; 
Meek & Werdinius, 1970), and DA 
(Grabowska et al., 1974 ; Halaris el al., 
1975 ; Bevan et al., 1975) metabolism in the 
brain and therefore it has been suggested 
that TCA induced-mania is related to 
central nor-adrenergic and dopaminergic 
systems (Bunney et al., 1972 ; Bunney et 
al., 1977 ; Gerner el al., 1976). The litera-
ture on TCA induced mania has largely 
focussed on the issue by assuming that the 
mania produced (in bipolar depressed as 
well as unipolar depressed patients) is part 
of the illness and TCA's have only helped 
to provoke it. No doubt, this appears 
to be a more easily grasped explanation 
but we must not overlook the possibility 
that this could be a late appearing side TRICYCLIC ANTI-DEPRESSANT INDUCED MANIA  383 
effect of TCA, probably of a toxic nature, 
with manifestations akin to mania. Of 
course, as pointed out earlier drug meta-
bolism may have an important role to 
play in this. We have been encouraged to 
propose the 'toxicity' theory because we 
observed that all of our patients had shown 
a marked alleviation of their depressive 
symptoms before they swung into mania. 
It may be that once the TCA's have restored 
the central amine balance they are no 
longer needed and if persisted with, may 
actually create a disbalance in the central 
biochemical substrate of a nature which 
leads to mania. However, since all de-
pressives on TCA therapy do not develop 
mania one should consider the possibility 
of an especially vulnerable group of patients. 
In conclusion we could like to mention 
that these cases demonstrate one of the 
potential hazards of TCA therapy, a fact 
which may easily be overlooked since mania 
occurs only too commonly as part of the 
illness. Clinically it may even be wise not 
to continue with TCA's as maintenance 
treatment for long once the patients show 
a good recovery and thus perhaps prevent 
cases of TCA-induced mania. 
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